KR830005871A - 광견병 백신의 제조방법 - Google Patents

광견병 백신의 제조방법 Download PDF

Info

Publication number
KR830005871A
KR830005871A KR1019810002356A KR810002356A KR830005871A KR 830005871 A KR830005871 A KR 830005871A KR 1019810002356 A KR1019810002356 A KR 1019810002356A KR 810002356 A KR810002356 A KR 810002356A KR 830005871 A KR830005871 A KR 830005871A
Authority
KR
South Korea
Prior art keywords
virus
inactivated
rabies
adjuvants
carriers
Prior art date
Application number
KR1019810002356A
Other languages
English (en)
Other versions
KR840001514B1 (ko
Inventor
폴 배스 에드먼드
레료이 샤피 리차드
Original Assignee
로버트 엘. 머피
노오던 라보라 토리즈, 인크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로버트 엘. 머피, 노오던 라보라 토리즈, 인크 filed Critical 로버트 엘. 머피
Publication of KR830005871A publication Critical patent/KR830005871A/ko
Application granted granted Critical
Publication of KR840001514B1 publication Critical patent/KR840001514B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

내용 없음

Description

광견병 백신의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 불활성화전 돼지 고환 세포 배양물중에서 성장시키기에 적합한 광견병 바이러스의 불활성화된 CHPSAD균주, 보조제 및 담체를 함유하는, 심각한 부작용없이 개 및 고양이와 동물에서 면역을 유도시킬 수 있는 불활성화 광견병 바이러스백신.
  2. 돼지 고환 세포 배양물중에서 관경병 바이러스의 HCP-SAD균주를 증식시키고 이 바이러스를 바이러스입자 또는 항원생성을 파괴하지 않는 불활성화제로 불활성화시키고 불활성화된 바이러스를 보조제 및 담체와 복합시킴을 특징으로 하여 특허 청구범위 1의 불활성화 광견병 백신을 제조하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019810002356A 1980-07-30 1981-06-30 광견병 백신의 제조방법 KR840001514B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US174306 1980-07-30
US06/174,306 US4347239A (en) 1980-07-30 1980-07-30 Inactivated rabies vaccine for veterinary use

Publications (2)

Publication Number Publication Date
KR830005871A true KR830005871A (ko) 1983-09-14
KR840001514B1 KR840001514B1 (ko) 1984-09-29

Family

ID=22635689

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810002356A KR840001514B1 (ko) 1980-07-30 1981-06-30 광견병 백신의 제조방법

Country Status (14)

Country Link
US (1) US4347239A (ko)
EP (1) EP0044920B1 (ko)
JP (1) JPS5732227A (ko)
KR (1) KR840001514B1 (ko)
AU (1) AU544338B2 (ko)
CA (1) CA1183452A (ko)
DE (1) DE3160560D1 (ko)
ES (1) ES500199A0 (ko)
HK (1) HK50184A (ko)
IE (1) IE50889B1 (ko)
NZ (1) NZ196214A (ko)
PH (3) PH17383A (ko)
SG (1) SG3384G (ko)
ZA (1) ZA811042B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664912A (en) * 1984-10-01 1987-05-12 Wiktor Tadeusz J Process for the large scale production of rabies vaccine
DE3526809A1 (de) * 1985-07-26 1987-04-02 Behringwerke Ag Tollwut-lebendimpfstoff
DE3682482D1 (de) * 1985-11-22 1991-12-19 Schweiz Serum & Impfinst Verfahren zur herstellung eines tollwutimpfstoffes und nach diesem verfahren erhaltener impfstoff.
US4990367A (en) * 1987-03-09 1991-02-05 Diamond Scientific Company Canine distemper virus vaccine
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
CN103336116B (zh) * 2010-06-22 2016-01-13 普莱柯生物工程股份有限公司 一种猪瘟活疫苗效力检验方法
RU2537183C2 (ru) * 2012-12-17 2014-12-27 Открытое Акционерное Общество "Институт Биотехнологий Ветеринарной Медицины" Способ получения инактивированной антирабической вакцины при безопорном выращивании клеток и репродукции в них вируса в укороченном цикле культивирования

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1030516B (de) * 1957-03-14 1958-05-22 Dr Med Gustav Seiffert Naehrboden zur Viruszuechtung
US3155589A (en) * 1958-04-14 1964-11-03 Upjohn Co Parenteral extravascular injectable vaccines for simultaneous immunization of canidae against rabies, canine distemper, and infectious canine hepatitis
US3397267A (en) * 1964-09-21 1968-08-13 Research Corp Method of producing rabies vaccine
US3423505A (en) * 1964-10-31 1969-01-21 Univ Toronto Rabies vaccine and process for preparation thereof
US3585266A (en) * 1969-02-24 1971-06-15 Dow Chemical Co Live rabies virus vaccine and method for the production thereof
US3769415A (en) * 1969-06-04 1973-10-30 Connaught Labor Ltd Method of preparing a killed vaccine for oral use
DE2162013C3 (de) 1971-12-14 1981-10-15 Johnson & Johnson, 08903 New Brunswick, N.J. Tollwut-Lebendimpfstoff, Verfahren zu seiner Herstellung nd seine Verwendung bei der Bekämpfung von Tollwut
FR2261779A1 (en) 1974-02-26 1975-09-19 Pasteur Institut Anti-rabies vaccine - obtd. from rabies virus grown on foetal calf kidney cells in a synthetic serum-free medium
FR2290220A2 (fr) 1974-11-05 1976-06-04 Pasteur Institut Nouveau vaccin antirabique
US4040904A (en) * 1975-07-21 1977-08-09 Slater Eban A Novel rabies virus vaccine and processes
DE2616407C3 (de) * 1976-04-14 1980-02-21 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Tollwut-Impfstoffs
US4070453A (en) * 1976-06-25 1978-01-24 Syntex (U.S.A.) Inc. Diploid porcine embryonic cell strains, cultures produced therefrom, and use of said cultures for production of vaccines
GB1596653A (en) 1977-01-26 1981-08-26 Gist Brocades Nv Vaccine
BE859178A (fr) 1977-09-29 1978-01-16 Cutter Lab Souche de cellules et culture de virus

Also Published As

Publication number Publication date
EP0044920A2 (en) 1982-02-03
PH22308A (en) 1988-07-22
CA1183452A (en) 1985-03-05
EP0044920B1 (en) 1983-07-06
SG3384G (en) 1985-02-01
EP0044920A3 (en) 1982-02-17
PH17383A (en) 1984-08-06
KR840001514B1 (ko) 1984-09-29
AU544338B2 (en) 1985-05-23
JPS5732227A (en) 1982-02-20
PH18743A (en) 1985-09-16
ZA811042B (en) 1982-05-26
DE3160560D1 (en) 1983-08-11
IE810240L (en) 1982-01-30
NZ196214A (en) 1984-07-31
AU6714381A (en) 1982-02-04
JPH0555487B2 (ko) 1993-08-17
ES8202357A1 (es) 1982-01-16
HK50184A (en) 1984-06-29
IE50889B1 (en) 1986-08-06
ES500199A0 (es) 1982-01-16
US4347239A (en) 1982-08-31

Similar Documents

Publication Publication Date Title
KR900001382A (ko) 연속 셀라인에서의 ibdv생성
DE3486495D1 (de) Hundecoronavirus
DK0400958T3 (da) Levende vacciner
DE3888652D1 (de) Vakzine.
SE7908516L (sv) Sett att framstella ett bakteriostatiskt material
KR830005871A (ko) 광견병 백신의 제조방법
ATE19591T1 (de) Virus der infektioesen katzen-bauchfellentzuendung, seine herstellung und es enthaltende vakzine.
ES2067921T3 (es) Una biomasa y un procedimiento para la produccion de virus/antigeno de virus.
IT1044555B (it) Benzodipironi e procedimento per prepararli
ATE43500T1 (de) Herstellung von antikoerpern.
SE8105079L (sv) Antibiotikum bmg162-af2
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
ES486442A0 (es) Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
DE3686158D1 (de) Impfstoff gegen mastitis.
ATE101044T1 (de) Gefluegelcolibacillose-vakzin.
KR900017611A (ko) 개의 코로나 바이러스 백신
IL67818A0 (en) Vaccines comprising ozone inactivated organisms and their production
FR2108935A1 (en) Sterile,diluted seawater - specific isotonic solns for treating haemorrhage,shock,diarrhoea in man and animals
GB8820835D0 (en) Plant breeding
KR870009018A (ko) 단순 포진에 대한 왁진
FR2150799A1 (en) Equine infectious anaemia - prepn of immunising vaccine
GB1105179A (en) Improvements in or relating to propagating human hepatitis virus
GB839876A (en) A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus
KR850000909A (ko) 활엽수 톱밥을 이용한 표고버섯 재배법
SU1692146A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура o